Acute Idiopathic Maculopathy Following SARS-CoV-2 Vaccination

Citation:

Bleicher ID, Brill D, Wu F, Sobrin L, Patel N. Acute Idiopathic Maculopathy Following SARS-CoV-2 Vaccination. Ocul Immunol Inflamm 2022;:1-4.

Date Published:

2022 Sep 02

Abstract:

A 49-year-old man presented with acute unilateral blurred vision one week after SARS-CoV-2 vaccination. A unilateral serous detachment of the macula, intraretinal hemorrhages, vitritis, and anterior chamber cell was found. Diagnostic testing was negative for infectious and inflammatory causes, and a diagnosis of acute idiopathic maculopathy (AIM) was made. Symptoms and serous detachment resolved over 12 weeks, with residual retinal pigment epithelial changes consistent with the disease course. AIM is a rare diagnosis that presented in close proximity to SARS-CoV-2 vaccination without evidence of coxsackievirus infection. Further research is necessary to clarify an association between this vaccine and uveitis.

Last updated on 10/01/2022